Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4175975
Max Phase: Preclinical
Molecular Formula: C31H42N2O9
Molecular Weight: 586.68
Molecule Type: Small molecule
Associated Items:
ID: ALA4175975
Max Phase: Preclinical
Molecular Formula: C31H42N2O9
Molecular Weight: 586.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1c(C)c(C)c2c(c1C)CCC(C)(C(=O)OC(C(=O)NC(C)(C)C)c1cccc(OCCCCO[N+](=O)[O-])c1)O2
Standard InChI: InChI=1S/C31H42N2O9/c1-19-20(2)26-24(21(3)25(19)38-8)14-15-31(7,42-26)29(35)41-27(28(34)32-30(4,5)6)22-12-11-13-23(18-22)39-16-9-10-17-40-33(36)37/h11-13,18,27H,9-10,14-17H2,1-8H3,(H,32,34)
Standard InChI Key: PAXOVWOVZSTAJK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 586.68 | Molecular Weight (Monoisotopic): 586.2890 | AlogP: 5.27 | #Rotatable Bonds: 12 |
Polar Surface Area: 135.46 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.26 | CX LogD: 6.26 |
Aromatic Rings: 2 | Heavy Atoms: 42 | QED Weighted: 0.15 | Np Likeness Score: -0.05 |
1. Ingold M, Dapueto R, Victoria S, Galliusi G, Batthyàny C, Bollati-Fogolín M, Tejedor D, García-Tellado F, Padrón JM, Porcal W, López GV.. (2018) A green multicomponent synthesis of tocopherol analogues with antiproliferative activities., 143 [PMID:29129514] [10.1016/j.ejmech.2017.11.003] |
Source(1):